FEATURED PARTNERSHIPS
European Association of Nuclear Medicine
Hermes Medical Solutions
is a proud sponsor of the EANM's PET learning facility in Vienna, Austria with the HERMES viewing stations in order to provide the highest standard of education on PET and its relation to other imaging modalities in Europe. Some HERMES user education/training will also take place at this facility. At each course 4 instructors will cover the presentations and case studies in "classroom style" in the lecture room. There will also be ample time for participants to view case studies in 4 viewing rooms, each equipped with state of the art HERMES dual monitor multipurpose viewing stations. One "industry viewing room" features workstations by all three major manufacturers of PET equipment.
Dana-Farber Cancer Institute &
Brigham and Women's Hospital
Hermes Medical Solutions is proud to have the Dana-Farber Cancer Institute and the Brigham and Women's Hospital in Boston, MA, USA, both teaching affiliates of Harvard Medical School as two of HERMES latest key customer relationships in the field of medical imaging solutions.
Reich Consulting Services, Inc.
Our specialty industries include imaging, managed care, nuclear medicine, PET/CT, radiation safety, real estate, surgery, and wound care. Our goal is to enhance value for our clients by diagnosing challenges, solving problems, creating new markets, and enhancing growth opportunities. We work hard on follow-up and reinforcement, and strive to build a strong, long-term, collaborative relationship with our customers.
Read more »» www.reichconsultingservices.com
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals is a clinical-stage, product-focused, molecular imaging company with significant expertise and IP in the field of molecular brain imaging. Avid has developed proprietary targeting agents to image amyloid plaques and is currently testing these compounds in clinical trials for the detection of Alzheimer's disease. Avid is also developing novel agents targeted to the vesicular monoamine transporter (VMAT-2) to image pathology in dementia with Lewy bodies (DLB), Parkinson's disease (PD), and Diabetes Mellitus (DM). Avid's molecular imaging agents have the potential to revolutionize the early diagnosis and monitoring of disease.
Read more »» www.avidrp.com
Karolinska University Hospital
Read more »»
www. karolinska.se
Fusion Diagnostic Group, LLC
Dr. Stephen R. Bunker, M.D. Clinical Dir. Nuclear Medicine, California Pacific Medical Center & Medical Director, Fusion Diagnostic Group, San Francisco, California.Read more »» www.fdg-inc.net